Comprehensive Solid Tumor Test Panel is an advanced, next generation sequencing-based translational research platform for precision oncology. The test evaluates over 1200 regions in 60 genes known to influence disease progression and response to treatment in solid tumors. The analysis includes assessment of single nucleotide variants, small insertions and deletions in coding and splicing regions for all 60 genes.